Form 144: Insider sells SYNA shares under 10b5-1

Morgan Stanley Smith Barney LLC submitted a Form 144 reporting proposed sales of Common shares tied to equity awards and recent 10b5-1 transactions by Lisa Bodensteiner.

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 reporting proposed sales of Common shares tied to equity awards and recent 10b5-1 transactions by Lisa Bodensteiner.

The filing lists Restricted Stock Units 288 and Performance Stock Units 288 dated 02/17/2026, and two 10b5-1 sales: 336 shares on 12/18/2025 for $25,478.88, and 7,182 shares on 12/09/2025 for $565,030.86.

Insights

Insider Trading Compliance Counsel

Filing documents planned/rescheduled sales under a broker‑facilitated plan and prior 10b5-1 executions.

The filing records two prior 10b5-1 executions by Lisa Bodensteiner: 7,182 shares on 12/09/2025 for $565,030.86 and 336 shares on 12/18/2025 for $25,478.88. These entries reflect executed sales rather than new purchases.

Timing and cash‑flow treatment are shown per the listed sale dates; any additional sales are tied to the listed equity award units dated 02/17/2026.

Equity Compensation Analyst

Filing lists award items (RSUs and PSUs) alongside reported share disposals, useful for tracking executive equity activity.

The record shows 288 Restricted Stock Units and 288 Performance Stock Units with an action date of 02/17/2026. These items are listed under "Securities To Be Sold" and appear alongside prior 10b5-1 sales.

Holder decisions and settlement mechanics will determine whether the listed units convert to marketable shares; subsequent filings would disclose further execution details.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Form 144 for SYNA report?

It reported proposed and completed share sales linked to equity awards and 10b5-1 plans. The filing lists 288 RSUs and 288 PSUs dated 02/17/2026, plus two executed 10b5-1 sales on 12/09/2025 and 12/18/2025.

Who executed the 10b5-1 sales in the SYNA filing?

Lisa Bodensteiner executed the 10b5-1 sales. The filing shows she sold 7,182 shares on 12/09/2025 for $565,030.86 and 336 shares on 12/18/2025 for $25,478.88.

How many equity award units are listed to be sold in the SYNA filing?

The filing lists 288 Restricted Stock Units and 288 Performance Stock Units. Both award lines carry the date 02/17/2026 in the provided excerpt and are described under "Securities To Be Sold."

Do the Form 144 entries show proceeds received by the issuer for SYNA?

The excerpt shows dollar amounts for executed 10b5-1 sales only. It records sale proceeds of $565,030.86 and $25,478.88 for the two executed trades; the filing does not state any issuer proceeds related to the listed RSUs/PSUs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 04:36 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001213272
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SYNAPTICS INCORPORATED
SEC File Number	000-49602
Address of Issuer	1109 McKay Dr. San Jose CALIFORNIA 95131
Phone	4089041100
Name of Person for Whose Account the Securities are To Be Sold	LISA BODENSTEINER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	576	49190.40	38729741	02/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2026	Restricted Stock Units	Issuer			288	02/17/2026	N/A
Common	02/17/2026	Performance Stock Units	Issuer			288	02/17/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for LISA BODENSTEINER 1109 McKay Dr. San Jose CA 95131	Common	12/18/2025	336	25478.88
10b5-1 Sales for LISA BODENSTEINER 1109 McKay Dr. San Jose CA 95131	Common	12/09/2025	7182	565030.86

144: Remarks and Signature

Remarks
Date of Notice	02/18/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Lisa Bodensteiner
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)